Clinical Trial Update: Study of EYP-1901 in Patients With Diabetic Macular Edema (DME) [Phase 2]

View source ↗

Summary

Phase 2 study of EYP-1901 for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• EYP-1901

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED